Next Dimension unveils 3-D software
Software developer Next Dimension Imaging this month introduced a line of clinical cardiology software based on 3-D ultrasound imaging methods. Out of its R&D in cardiac imaging, the company has developed OEM software toolkits that it licenses to
Software developer Next Dimension Imaging this month introduced a line of clinical cardiology software based on 3-D ultrasound imaging methods. Out of its R&D in cardiac imaging, the company has developed OEM software toolkits that it licenses to companies with 3-D products. Next Dimension has developed a range of clinical products with its toolkits intended to enhance the efficiency of 3-D ultrasound systems.
The companys 3-D PlaneView and 3-D LV-View both use a plane-reconstruction engine for stacks of nonparallel images common in 3-D ultrasound acquisition. With 3-D LV-View, physicians can track the morphology and mobility of cardiac tumors and masses through virtual object modeling.
Next Dimension of Longmont, CO, was founded in 1996 by Lothar Muench and is relatively new to software development. In the past, the company has primarily offered consulting services for 3-D acquisition, processing, visualization, and OEM software.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.
